Ardena Opens Bioanalytical Lab in Oss, Netherlands

• Ardena has opened a new bioanalytical laboratory at Pivot Park in Oss, the Netherlands.

• The facility has already initiated client projects and completed its first sample testing in April.

Ardena, a specialist in integrated drug development, has opened a new bioanalytical laboratory in Oss, the Netherlands. The facility, located at Pivot Park, was commissioned earlier this year and began its first sample testing in April.

The new site adds over 3,000 square feet of laboratory space to Ardena’s European bioanalytical network. It is designed to support both small and large molecule programmes, offering advanced technologies such as LC-MS/MS systems and immunochemistry platforms including MSD and Gyrolab.

The Oss lab is positioned to complement Ardena’s existing Bioanalytical Center of Excellence in Assen. According to the company, it will provide additional capacity, operational flexibility, and improved lead times for time-sensitive clinical trials.

“We are proud to see the first client programs underway in Oss,” said Gunnar Flik, Division Head of Bioanalytical Services at Ardena. “The lab was built to offer fast, flexible support to biopharma innovators navigating increasingly complex clinical trials.”

The launch of the Oss site comes ahead of Ardena’s planned expansion into the US, with a bioanalytical lab set to open in Somerset, New Jersey in Q3 2025. The company said this network of facilities aims to deliver global clinical trial support with local execution.